AIM2 and neoplasm: Research has shown that activation of the AIM2 inflammasome in nasopharyngeal carcinoma leads to increased secretion of tumor-derived IL-1β, resulting in the recruitment of a significant population of tumor-associated neutrophils (TANs) and suppression of tumor growth in murine models26.